Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Retained Earnings (2017 - 2025)

Historic Retained Earnings for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to -$262.7 million.

  • Q32 Bio's Retained Earnings fell 1908.12% to -$262.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$262.7 million, marking a year-over-year decrease of 1908.12%. This contributed to the annual value of -$234.8 million for FY2024, which is 2551.46% down from last year.
  • Latest data reveals that Q32 Bio reported Retained Earnings of -$262.7 million as of Q3 2025, which was down 1908.12% from -$255.3 million recorded in Q2 2025.
  • Q32 Bio's Retained Earnings' 5-year high stood at -$186.1 million during Q1 2024, with a 5-year trough of -$526.0 million in Q3 2023.
  • Its 5-year average for Retained Earnings is -$331.3 million, with a median of -$332.0 million in 2022.
  • In the last 5 years, Q32 Bio's Retained Earnings tumbled by 4018.47% in 2021 and then surged by 5936.68% in 2024.
  • Q32 Bio's Retained Earnings (Quarter) stood at -$424.1 million in 2021, then fell by 1.18% to -$429.1 million in 2022, then surged by 56.41% to -$187.1 million in 2023, then decreased by 25.51% to -$234.8 million in 2024, then decreased by 11.89% to -$262.7 million in 2025.
  • Its last three reported values are -$262.7 million in Q3 2025, -$255.3 million for Q2 2025, and -$245.8 million during Q1 2025.